Navigation Links
Difficult Pregnancy Linked to Premature Heart Problems

The risk of becoming a victim to heart disease increased if the infant died in the womb or its growth was restricted by any external factors. "The risk of premature cardiovascular disease is higher after a maternal placental syndrome, //especially when the fetus is adversely affected," said Dr Joel Ray, a lead researcher of the study. "We believe the maternal placental syndrome should be considered as an additional risk factor for cardiovascular disease."

Dr. Ray says that women should have their blood pressure checked six months after the birth to know if it within normal limits. Heart disease or cardiovascular disease is the leading cause of death worldwide and a high blood pressure, obesity, raised cholesterol levels, smoking and insulin resistance are all high risk factors for the development of the disease. In the current study, the scientists monitored over 1 million healthy women in Canada and probed for a link between placenta problems and the development of premature heart disease. Among these women, around 75,000 were diagnosed with maternal placental syndrome. This syndrome includes the condition where the blood vessels within the placenta are blocked, thus signaling a difficult pregnancy. "With a pandemic of obesity in our midst, including a more than doubling of the number of obese women at antenatal booking, we should try to ensure that women are a healthy weight before they enter their reproductive years," Dr. Ray concluded.

The details of the study are published in an article in the latest issue of The Lancet
'"/>




Page: 1

Related medicine news :

1. HRT: A Difficult Decision
2. Help For Kids With Difficulty In Sleeping
3. Asthma Patients With Sinusitis More Difficult To Treat
4. Sperm Retrieval, Difficult in Klinefelter’s Syndrome Patients after 35 Year
5. Premature Babies Give It Their Best Shot To Overcome Difficulty
6. Older Women Who Are Avid Watchers of the Tube Have Cognitive Difficulties
7. Maternal Difficulties Increase Risk of Behavior Problems in Children
8. TV Viewing Might Increase The Risk Of Sleeping Difficulties In Children’
9. Female Genital Mutilation May Lead To Difficult Childbirth:Rep
10. Obesity Makes Treatment of HCV Difficult
11. Gait Difficulties Associated with High Blood Pressure
Post Your Comments:
Breaking Medicine Technology:Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 54884 1Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 54884 2Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute 54884 3Reliv Walk for the Mission Raises Approximately 2447 000 for Malnourished People 54882 1Reliv Walk for the Mission Raises Approximately 2447 000 for Malnourished People 54882 2N2Care Unveils Backyard Smart MEDcottage 54880 1N2Care Unveils Backyard Smart MEDcottage 54880 2
Other Medicine Technology:Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 2Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 3Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 4Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 5Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 6Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 7Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year 2Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year 3Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year 4